Maisprach, Switzerland

Peter Pietzonka

This inventor holds 2 USPTO granted patents. Top assignee: Novartis Ag. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Pietzonka. Retrieved from https://idiyas.com/inventor/peter-pietzonka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Peter Pietzonka

Introduction

Peter Pietzonka is an accomplished inventor based in Maisprach, Switzerland. Known for his innovative contributions, he holds two patents that enhance the field of pharmaceutical developments. His work at a prominent company underlines his commitment to advancing healthcare solutions.

Latest Patents

Among Peter's notable patents is his work on Combined Capsule and Tablets. This innovation seeks to streamline medication delivery by combining the efficiency of capsules and tablets into a single dosage form. Such a development has the potential to simplify treatment regimens for patients and improve adherence to medication instructions.

Career Highlights

Peter is currently employed by Novartis AG, a global healthcare company that focuses on innovative medicines. His role at Novartis positions him at the forefront of pharmaceutical research and development, allowing him to work on pioneering projects that can transform patient care.

Collaborations

In his career, Peter has collaborated with talented individuals such as Jean-Daniel Bonny and Stefan Hirsch. These partnerships reflect a dynamic work environment where collective expertise and shared visions drive innovation.

Conclusion

Peter Pietzonka exemplifies the spirit of innovation in the pharmaceutical industry. His patents not only reflect his technical expertise but also his dedication to improving health outcomes for patients worldwide. As he continues to work at Novartis AG, there is no doubt that he will contribute to future advancements in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…